Thursday, October 23, 2025

3:40 PM - 4:25 PM

---

Overview

Sponsored by: RADIUM CAPITAL

---

Details

The Research & Development Tax Incentive (R&DTI) is a flagship Government program designed to stimulate innovation across sectors, with particularly transformative effects in the life sciences industry. This session will explore how companies in biotechnology, pharmaceuticals, and medical technology are leveraging R&D tax incentives to accelerate the development of groundbreaking therapies and diagnostics and enhance global competitiveness. Comprising of an R&D tax expert, IP commercialisation lawyer and R&D financier, this panel will examine case studies, highlight common eligibility pitfalls, and share strategic insights on maximising claims. The session will also showcase the impact of the R&DTI on Australian innovation through real-world examples and discussion with biotech companies. Attendees will gain practical guidance on how to structure projects and reporting to optimise access to the program, particularly in light of evolving regulations and audit scrutiny. This session is essential for life sciences executives, CFOs, R&D managers, and policy stakeholders aiming to unlock the full value of innovation incentives while driving scientific and commercial success. Sponsored by:

---

Speaker